| (210) | Number of the EPO application | 18382287 |
| (220) | Filing date of the EPO application | 2018.04.27 |
| (80) | EPO patent specification publication (B) | EPB nr. 20/2019, 2019.05.15 |
| (110) | EPO patent number | 3395820 |
| (11) | Number of the document | MD 3395820 T2 |
| (21) | Number of the application | e 2018 1216 |
| (71) | Name(s) of applicant(s), code of the country | Pharma Mar, S.A., ES; |
| (72) | Name(s) of inventor(s), code of the country | CUEVAS MARCHANTE María del Carmen, ES;
FRANCESCH SOLLOSO Andrés, ES;
MARTÍNEZ BARRASA Valentín, ES; |
| (73) | Name(s) of owner(s), code of the country | PHARMA Mar S.A., ES; |
| (54) | Title of the invention | Antitumoral compounds |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 515/22 (2006.01.01); A61P 35/00 (2006.01.01); A61K 31/4995 (2006.01.01) |
| (19) | Country | ES |
| (41) | Date of publication of the application | 2019.01.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2019.10.31 |
| (30) | Priority | 17382228, 2017.04.27, EP; 17382497, 2017.07.26, EP |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |